Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

Mariendistel Formula 100 mg Capsule is a Health Canada–registered human drug (DIN 02237839) held by Naka Sales Ltd., containing Cynara Scolymus. Health Canada lists its status as Cancelled Post Market (status date 23 Jul 2001). Nexara Health has matched 2 registrations of Cynara Scolymus across 1 other regulated market.

Health Canada registration

DIN02237839
Brand nameMariendistel Formula
Active ingredientCynara Scolymus
Strength100 mg
Dosage formCapsule
RouteOral
CompanyNaka Sales Ltd.
StatusCancelled Post Market — 23 Jul 2001
ClassHuman
ATC
AHFS84:04.92
Regulator recordHealth Canada DPD entry · Product monograph

Cynara Scolymus registered in other markets

2 registrations of the same molecule in 1 national registry outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.

CountryProductMarketing authorisation holderStrengthFormStatusRegistry
NetherlandsCynara scolymusBOIRON (Messimy)4 DH t/m 60 DH#2 CH t/m 200 CH#6 K t/m 100.000 K#1 LM t/m 30 LMUitsluitend apotheek of drogistEU national register
NetherlandsCynara scolymusBOIRON (Messimy)4 DH t/m 60 DH#2 CH t/m 200 CH#6 K t/m 100.000 K#1 LM t/m 30 LMGlobuliUitsluitend apotheek of drogistEU national register

See every manufacturer of Cynara Scolymus worldwide →

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Mariendistel Formula (DIN 02237839) marketed in Canada?

No. Health Canada lists DIN 02237839 as Cancelled Post Market as of 23 Jul 2001.

Who holds the Canadian licence for this product?

Naka Sales Ltd. is the company of record in the Health Canada Drug Product Database.

Is Cynara Scolymus registered outside Canada?

Yes — Nexara Health has matched 2 registrations in 1 other market (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 02237839, status date 2001-07-23; national medicine registries: EU national register. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 02237839, status date 2001-07-23; national medicine registries: EU national register.

Health Canada Drug Product Database (DPD), DIN 02237839, status date 2001-07-23; national medicine registries: EU national register. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.